Insider Transactions in Q1 2023 at Health Catalyst, Inc. (HCAT)
Insider Transaction List (Q1 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 22
2023
|
Paul Horstmeier Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
50,000
+19.62%
|
$200,000
$4.42 P/Share
|
|
Mar 03
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
760
-0.33%
|
$10,640
$14.34 P/Share
|
|
Mar 03
2023
|
Jason Alger Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,967
-5.09%
|
$41,538
$14.23 P/Share
|
|
Mar 01
2023
|
Paul Horstmeier Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,464
-2.8%
|
$62,496
$14.29 P/Share
|
|
Mar 01
2023
|
Daniel D. Burton Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,717
-0.88%
|
$108,038
$14.29 P/Share
|
|
Mar 01
2023
|
Daniel H. Orenstein General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
2,186
-1.62%
|
$30,604
$14.29 P/Share
|
|
Mar 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,083
+0.85%
|
-
|
|
Mar 01
2023
|
Kevin Lee Freeman Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,569
-0.87%
|
$21,966
$14.29 P/Share
|
|
Mar 01
2023
|
Linda Llewelyn Chief People Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,734
-2.06%
|
$24,276
$14.29 P/Share
|
|
Mar 01
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,351
-1.41%
|
$46,914
$14.29 P/Share
|
|
Mar 01
2023
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
1,142
+1.92%
|
-
|
|
Mar 01
2023
|
Jason Alger Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
1,614
-2.75%
|
$22,596
$14.29 P/Share
|
|
Feb 22
2023
|
Linda Llewelyn Chief People Officer |
BUY
Grant, award, or other acquisition
|
Direct |
35,000
+29.4%
|
-
|
|
Feb 22
2023
|
Daniel H. Orenstein General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
40,000
+22.82%
|
-
|
|
Feb 22
2023
|
Bryan Truman Hunt Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+29.68%
|
-
|
|
Feb 22
2023
|
Jason Alger Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+29.85%
|
-
|
|
Feb 15
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
662
-1.33%
|
$8,606
$13.82 P/Share
|
|
Jan 18
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,354
-1.69%
|
$28,248
$12.53 P/Share
|
|
Jan 17
2023
|
Bryan Truman Hunt Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
2,055
-1.45%
|
$24,660
$12.0 P/Share
|
|
Jan 17
2023
|
Linda Llewelyn Chief People Officer |
SELL
Open market or private sale
|
Direct |
642
-1.28%
|
$7,704
$12.12 P/Share
|